Evidence map›Paper›PMID 25572397›Full record

ArticleThe Journal of biological chemistry2015

Mechanisms mediating enhanced neutralization efficacy of staphylococcal enterotoxin B by combinations of monoclonal antibodies.

Kaushik Dutta, Avanish K Varshney, Matthew C Franklin, Michael Goger, Xiaobo Wang, Bettina C Fries

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. mRNA: A Novel Avenue to Antibody Therapy?Molecular therapy : the journal of the American Society of Gene Therapy · 2019
    Review
  15. Review
  16. Engineering therapeutic antibodies to combat infectious diseases.Current opinion in chemical engineering · 2018
    Article
  17. Structure of the staphylococcal enterotoxin B vaccine candidate S19 showing eliminated superantigen activity.Acta crystallographica. Section F, Structural biology communications · 2017
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Kaushik DuttaFrom the New York Structural Biology Center, New York, New York 10027, dutta@nysbc.org.
Avanish K Varshneythe Department of Medicine and Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York 11790, and the Department of Medicine, Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461.
Matthew C FranklinFrom the New York Structural Biology Center, New York, New York 10027.
Michael GogerFrom the New York Structural Biology Center, New York, New York 10027.
Xiaobo Wangthe Department of Medicine, Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461.
Bettina C Friesthe Department of Medicine and Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York 11790, and the Department of Medicine, Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461 Bettina.Fries@stonybrookmedicine.edu.
New York Structural Biology Center · USStony Brook University · USAlbert Einstein College of Medicine · US

Funding

Viral Pathogenesis and TherapeuticsU54AI057158 · NIAID · WADSWORTH CENTER · PI LEVY, DAVID E · 2003 to 2014
$100.8M
Life Science and Biomedical technology Research center at NSLS-II LSBRP41GM111244 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI MCSWEENEY, SEAN · 2014 to 2018
$16.4M
900 MHz NMR Spectrometer for Structural BiologyP41GM066354 · NIGMS · NEW YORK STRUCTURAL BIOLOGY CENTER · PI COWBURN, DAVID · 2002 to 2006
$4.7M
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR015495 · NCRR · NEW YORK STRUCTURAL BIOLOGY CENTER · PI RIFKIND, RICHARD A · 2000 to 2000
$2.0M
Development of antibodies to capsule of carbapenem resistant Klebsiella pneumoniaR21AI114259 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI FRIES, BETTINA · 2015 to 2016
$435k
NCRR NIH HHS C06 RR015495NIAID NIH HHS R21 AI114259NIAID NIH HHS U54 AI057158NIGMS NIH HHS P41 GM066354NIGMS NIH HHS P41GM066354NIGMS NIH HHS P41 GM111244
6 · The paper itself

Abstract

Staphylococcal enterotoxin B (SEB) is a superantigen that cross-links the major histocompatibility complex class II and specific V-β chains of the T-cell receptor, thus forming a ternary complex. Developing neutralizing mAb to disrupt the ternary complex and abrogate the resulting toxicity is a major therapeutic challenge because SEB is effective at very low concentrations. We show that combining two SEB-specific mAbs enhances their efficacy, even though one of the two mAbs by itself has no effect on neutralization. Crystallography was employed for fine-mapping conformational epitopes in binary and ternary complexes between SEB and Fab fragments. NMR spectroscopy was used to validate and identify subtle allosteric changes induced by mAbs binding to SEB. The mapping of epitopes established that a combination of different mAbs can enhance efficacy of mAb-mediated protection from SEB induced lethal shock by two different mechanisms: one mAb mixture promoted clearance of the toxin both in vitro and in vivo by FcR-mediated cross-linking and clearance, whereas the other mAb mixture induced subtle allosteric conformational changes in SEB that perturbed formation of the SEB·T-cell receptor·major histocompatibility complex class II trimer. Finally structural information accurately predicted mAb binding to other superantigens that share conformational epitopes with SEB. Fine mapping of conformational epitopes is a powerful tool to establish the mechanism and optimize the action of synergistic mAb combinations.

Indexed as

Amino Acid SequenceAnimalsAntibodies, MonoclonalCrystallography, X-RayEnterotoxinsEpitope MappingEpitopesImmunotherapyMiceMolecular Docking SimulationMolecular Sequence DataSequence AlignmentStaphylococcal InfectionsStaphylococcus aureusSuperantigensAntibodies, Monoclonalenterotoxin B, staphylococcalEnterotoxinsEpitopesSuperantigensBacterial ToxinCrystal StructureEpitope MappingMonoclonal AntibodyNuclear Magnetic Resonance (NMR)SEBStaphylococcal Enterotoxin BX-ray Crystallography

Identifiers

PMID25572397
PMCPMC4358096
OpenAlexW2045144262

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.